[Controlled clinical study on the use of morniflumate in the treatment of inflammatory-degenerative diseases of the locomotor system].
G
G
Raffaetà
G
G
Saponati
A
A
Terzuoli
D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007592:Joint Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use*; D009544:Niflumic Acid / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*; D010147:Pain Measurement; D011897:Random Allocation
D000894:Anti-Inflammatory Agents, Non-Steroidal; D009539:Nicotinic Acids; D009544:Niflumic Acid; C027859:morniflumate
Studio clinico controllato sull'impiego del morniflumato nel trattamento delle affezioni flogistico-degenerative dell'apparato locomotore.